GRCE Award Disclosure
Kumar Amresh · SEC Form 4 · Filed Sep 1, 2026
Award
Calculated transaction value
$0
Kumar Amresh VP Program Management
GRCE
Grace Therapeutics
GRCE
Transaction date
Aug 28, 2026
Public filing date
Sep 1, 2026
Filing lag
Filed 4 days later
GRCE daily price context
Close on/before transaction
$2.12
Aug 28, 2026
Close before public filing
$2.13
Aug 31, 2026
Return since public filing
+4.23%
Through Sep 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (Right to Buy) on Common Stock
- Quantity / price
- 35,760 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001140361-26-035318
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Grace Therapeutics, Inc. GRCE Current | Award | Aug 28, 2026 | $0 |